Johnson & Johnson MedTech (J&J MedTech) has launched the Cereglide 92 Catheter System, a next-generation .092” catheter with the Innerglide 9 delivery aid.
The catheter system is designed for use in the neurovascular system, supporting the insertion and guidance of interventional devices for the treatment of acute ischemic strokes.
With a .092″ inner diameter, the system allows physicians to achieve large distal access and provides flow reduction in the M1 territory during revascularisation procedures.
Its larger lumen also provides distal support for multiple neurovascular tools when addressing aneurysms and other haemorrhagic complications.
J&J MedTech said that Cereglide 92 is the latest catheter in its portfolio to integrate with Stroke Solutions, such as Cereglide 71, Prowler EX and Embotrap III.
Johnson & Johnson MedTech neurovascular worldwide president Mark Dickinson said: “Johnson & Johnson MedTech is continuing to innovate to help address the access challenges physicians face during mechanical thrombectomy procedures with the launch of Cereglide 92.
“The Cereglide 92 catheter system is the latest innovation in our Cereglide and ischemic stroke suite of technologies designed to assist physicians in treating their patients and maximising procedural outcomes, to ultimately change the trajectory of stroke.”
According to the company, acute ischemic strokes account for 85% of all strokes worldwide and the M1 territory is the most affected by stroke.
J&J MedTech said its Cereglide 92 catheter system facilitates the insertion of aspiration catheters during thrombectomy procedures.
The catheter enables physicians to restore blood flow in the brain by directly withdrawing a blood clot or using a catheter in conjunction with a stent retriever.
More than half of the ischemic stroke patients are treated with mechanical thrombectomy.
However, some patients remain untreated or experience poor outcomes due to limited access and challenges in navigating the complex anatomy of the brain.
The Cereglide 92 catheter system comes with design elements such as the co-packaged Innerglide 9 Delivery Aid, Brite-Line Technology, and TruCourse Technology.
The design elements enhance distal tip flexibility and catheter trackability and provide procedural control and full visibility under fluoroscopy.
Also, J&J MedTech designed the catheter system to use electronic instructions for use (e-IFUs), as part of its ongoing sustainability efforts.
E-IFUs aim to reduce the environmental footprint, lower CO2 emissions during shipment, and decrease healthcare systems’ post-consumer recycling and medical waste disposal.
